Jong Seok Kim

Learn More
Intracranial atherosclerosis (ICAS) is a major cause of stroke worldwide and is more common in Asians than Caucasians. The study results from the East and West are generally similar, but notable differences exist. For example, studies from the East have reported that ICAS is associated with young age, whereas ICAS seems to be associated with old age in the(More)
Evidence suggests that combined gemcitabine-cisplatin chemotherapy extends survival in patients with advanced biliary tract cancer (BTC). We conducted a systematic review in order to collate this evidence and assess whether gemcitabine-cisplatin efficacy is influenced by primary tumor site, disease stage, or geographic region, and whether associated(More)
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Aside from cancer, stroke has long been the number one cause of death in Korea, followed by heart disease. Last year, our gov­ ernment reported that this order was reversed, due primarily to a decrease in stroke mortality(More)
The aim of this study was to determine whether socialized Jindo puppies would show different behavioral reactivity from non-socialized puppies. Puppies (n=12), 7 weeks of age, were divided into socialized and non-socialized groups. The socialized group from the 7th until 13th week after birth was provided a socialization program, and the non-socialized(More)
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Moyamoya disease (MMD) is a chronic occlusive cerebro-vascular disease characterized by progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. The(More)
Post-stroke mood and emotional disturbances are frequent and diverse in their manifestations. Out of the many post-stroke disturbances, post-stroke depression, post-stroke anxiety, post-stroke emotional incontinence, post-stroke anger proneness, and post-stroke fatigue are frequent and important symptoms. These symptoms are distressing for both the patients(More)
PURPOSE We recently reported on a randomized, open-label, phase 3 trial comparing pemetrexed-cisplatin chemotherapy followed by gefitinib maintenance therapy (PC/G) with gefitinib monotherapy in patients with non-small cell lung cancer (NSCLC). Here, we report on a post hoc subgroup analysis of that study assessing the demographics and disposition of the(More)